{"id":"NCT02979899","sponsor":"Tracon Pharmaceuticals Inc.","briefTitle":"Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma","officialTitle":"A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma (TAPPAS)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-02-13","primaryCompletion":"2019-04-11","completion":"2019-08-31","firstPosted":"2016-12-02","resultsPosted":"2020-05-12","lastUpdate":"2020-05-12"},"enrollment":128,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Advanced Angiosarcoma"],"interventions":[{"type":"BIOLOGICAL","name":"TRC105","otherNames":["anti-endoglin antibody","carotuximab"]},{"type":"DRUG","name":"Votrient","otherNames":["pazopanib"]}],"arms":[{"label":"TRC105 plus votrient","type":"EXPERIMENTAL"},{"label":"votrient","type":"ACTIVE_COMPARATOR"}],"summary":"This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not amenable to curative intent surgery (e.g., metastatic or bulky disease, and disease for which surgical resection would carry an unacceptable risk to the patient) who have not received pazopanib or TRC105 previously.","primaryOutcome":{"measure":"Progression Free Survival of Patients With Unresectable Angiosarcoma","timeFrame":"from date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to cut off date of interim analysis (25 months)","effectByArm":[{"arm":"TRC105 + Votrient","deltaMin":4.2,"sd":null},{"arm":"Votrient","deltaMin":4.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":39,"countries":["United States","Austria","France","Germany","Italy","Poland","Spain","United Kingdom"]},"refs":{"pmids":["35357396","30357394"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":27,"n":63},"commonTop":["Fatigue","Diarrhea","Nausea","Hypertension","Headache"]}}